Updated daily
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 41211763 | 0 | Wang TF, Yeo E, Gross PL, et al. A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study. Am J Hematol. 2025 Nov 10. doi: 10.1002/ajh.70127. | |
| 41161416 | 0 | Mai V, Takada T, Kraaijpoel N, et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Patients with Chronic Lung Disease: An Individual-Patient Data Meta-Analysis. J Thromb Haemost. 2025 Oct 27:S1538-7836(25)00667-1. doi: 10.1016/j.jtha.2025.10.004. | |
| 40846029 | 0 | Righini M, Robert-Ebadi H, Galanaud JP, et al. JTH IN CLINIC: MANAGEMENT OF ISOLATED DISTAL DEEP VEIN THROMBOSIS. J Thromb Haemost. 2025 Aug 20:S1538-7836(25)00525-2. doi: 10.1016/j.jtha.2025.08.006. | |
| 40769433 | 0 | Omar D, Kovacs MJ, Lazo-Langner A, et al. Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism. J Thromb Haemost. 2025 Aug 4:S1538-7836(25)00489-1. doi: 10.1016/j.jtha.2025.07.026. | |
| 40765707 | 0 | Karsanji D, King JA, Godley J, et al. Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. Blood Vessel Thromb Hemost. 2024 Feb 24;1(1):100004. doi: 10.1016/j.bvth.2024.100004. eCollection 2024 Mar. | |
| 40680941 | 0 | Sharma S, Soon L, de Wit K, et al. Validation of the ToDay, a Simplified Diagnostic Algorithm for Deep Vein Thrombosis. J Thromb Haemost. 2025 Jul 16:S1538-7836(25)00418-0. doi: 10.1016/j.jtha.2025.06.029. | |
| 40673044 | 0 | Falanga A, Le Gal G, Carrier M, et al. Corrigendum: Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives. TH Open. 2025 Jul 10;9:s00451810091. doi: 10.1055/s-0045-1810091. eCollection 2025. | |
| 40579365 | 0 | Khan F, Tritschler T, Marx CE, et al. Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis. Eur Heart J. 2025 Jun 22:ehaf453. doi: 10.1093/eurheartj/ehaf453. | |
| 40578691 | 0 | Mai V, Martens ESL, Righini M, et al. Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019. | |
| 40496572 | 0 | Godier A, Lasne D, Martin AC, et al. Management of bleeding and invasive procedures in patients treated with anti-factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis. Res Pract Thromb Haemost. 2025 Apr 17;9(3):102860. doi: 10.1016/j.rpth.2025.102860. eCollection 2025 Mar. | |
| 40486212 | 0 | Le Roux PY, Robin P, Le Pennec R, et al. Residual pulmonary vascular obstruction computed with ventilation/perfusion single photon emission computed tomography/computed tomography to predict the risk of venous thromboembolism recurrence in patients with pulmonary embolism: protocol for a cohort study (PRONOSPECT). Res Pract Thromb Haemost. 2025 Apr 22;9(3):102867. doi: 10.1016/j.rpth.2025.102867. eCollection 2025 Mar. | |
| 40475025 | 0 | Najaf Zadeh S, Schmidli F, Jalowiec KA, et al. Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary Thrombosis Centre in Switzerland. Res Pract Thromb Haemost. 2025 Apr 17;9(3):102864. doi: 10.1016/j.rpth.2025.102864. eCollection 2025 Mar. | |
| 40447349 | 0 | Klok FA, Woller SC, Schwartz A, et al. Optimising communication to patients with venous thromboembolism: development of a provider toolkit. Lancet Haematol. 2025 Jun;12(6):e411-e412. doi: 10.1016/S2352-3026(25)00136-X. | |
| 40404047 | 0 | Hammache M, Simard C, Hamel S, et al. Diagnosing pulmonary embolism during pregnancy: A narrative review. Chest. 2025 May 20:S0012-3692(25)00649-X. doi: 10.1016/j.chest.2025.05.014. | |
| 40327961 | 0 | Brown C, Mallick R, Pecarskie A, et al. Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapy. Thromb Res. 2025 Apr 30;250:109335. doi: 10.1016/j.thromres.2025.109335. | |
| 40290673 | 0 | Mishra S, Klok FA, Le Gal G, et al. An assessment of evidence to inform best practice for the communication of acute venous thromboembolism diagnosis: a scoping review. Res Pract Thromb Haemost. 2025 Mar 23;9(3):102835. doi: 10.1016/j.rpth.2025.102835. eCollection 2025 Mar. | |
| 40288681 | 0 | Siegal DM, Arsenault MP, Abdulrehman J, et al. Venous Thromboembolism after Hospitalization for COVID-19: Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO) Study. J Thromb Haemost. 2025 Apr 25:S1538-7836(25)00268-5. doi: 10.1016/j.jtha.2025.04.018. | |
| 40216708 | 0 | Makedonov I, Kapitanski L, Giai J, et al. Treatment of isolated distal deep vein thrombosis: an international survey of healthcare professionals. J Thromb Thrombolysis. 2025 Apr 11. doi: 10.1007/s11239-025-03091-5. | |
| 40162636 | 0 | Mahe I, Carrier M, Mayeur D, et al. Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMoa2416112. | |
| 39848545 | 0 | Bezerra OCL, Rodger M, Munsch G, et al. Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. J Thromb Haemost. 2025 Jan 21:S1538-7836(25)00010-8. doi: 10.1016/j.jtha.2025.01.004. | |
| 39715559 | 0 | Vale CL, Godolphin PJ, Fisher DJ, et al. Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis. Ann Intern Med. 2025 Jan;178(1):59-69. doi: 10.7326/ANNALS-24-00800. Epub 2024 Dec 24. | |
| 39603673 | 0 | Delluc A, Pradier M, Siegal DM, et al. Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis. Eur Respir J. 2024 Nov 27:2401596. doi: 10.1183/13993003.01596-2024. | |
| 39447869 | 0 | Godier A, Lasne D, Pernod G, et al. Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network. Anaesth Crit Care Pain Med. 2024 Oct 22:101446. doi: 10.1016/j.accpm.2024.101446. | |
| 39442625 | 0 | Anuku D, Carrier M, Le Gal G, et al. Impact of limited language proficiency on participation in venous thromboembolism research: A retrospective analysis. J Thromb Haemost. 2024 Oct 21:S1538-7836(24)00562-2. doi: 10.1016/j.jtha.2024.09.014. | |
| 38938844 | 0 | Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar. | |
| 38904133 | 0 | Mai V, Girardi L, de Wit K, et al. Chronic obstructive pulmonary disease exacerbation purulence status and its association with pulmonary embolism: protocol for a systematic review with meta-analysis. BMJ Open. 2024 Jun 19;14(6):e085328. doi: 10.1136/bmjopen-2024-085328. | |
| 38781706 | 0 | Girardi L, Ciuffini LA, Mai V, et al. Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism. Thromb Res. 2024 May 17;239:109037. doi: 10.1016/j.thromres.2024.109037. | |
| 38444614 | 0 | Chiang P, Robert-Ebadi H, Perrier A, et al. Pulmonary embolism risk stratification: external validation of the 4-level Clinical Pretest Probability Score (4PEPS). Res Pract Thromb Haemost. 2024 Feb 15;8(1):102348. doi: 10.1016/j.rpth.2024.102348. eCollection 2024 Jan. | |
| 38422980 | 0 | Bhangu G, Murray A, Qayyum A, et al. Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review. Thromb Res. 2024 Feb 19;236:108-116. doi: 10.1016/j.thromres.2024.02.012. | |
| 38320142 | 0 | Mottier D, Girard P, Couturaud F, et al. Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients. NEJM Evid. 2023 Aug;2(8):EVIDoa2200332. doi: 10.1056/EVIDoa2200332. Epub 2023 Jun 27. | |
| 38320119 | 0 | Le Gal G, Mottier D. Challenges Faced and Lessons Learned from Our Trial of VTE Prophylaxis. NEJM Evid. 2023 Sep;2(9):EVIDctcs2300050. doi: 10.1056/EVIDctcs2300050. Epub 2023 Aug 22. | |
| 38187826 | 0 | Mathieu ME, Duffett L, Caiano L, et al. Management and outcomes of superficial vein thrombosis: a single-center retrospective study. Res Pract Thromb Haemost. 2023 Nov 18;8(1):102263. doi: 10.1016/j.rpth.2023.102263. eCollection 2024 Jan. | |
| 38030465 | 0 | Le Gal G, Agnelli G, Darius H, et al. Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis. Eur J Intern Med. 2024 Mar;121:48-55. doi: 10.1016/j.ejim.2023.11.017. Epub 2023 Nov 29. | |
| 37806116 | 0 | Rambaud G, Mai V, Motreff C, et al. Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial. Thromb Res. 2023 Sep 28;231:58-64. doi: 10.1016/j.thromres.2023.09.013. | |
| 37801772 | 0 | Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012. | |
| 37517478 | 0 | Marx CE, Schenker C, Xu Y, et al. Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort. J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015. | |
| 37452732 | 0 | van Es N, Takada T, Kraaijpoel N, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023 Jul 15:ehad417. doi: 10.1093/eurheartj/ehad417. | |
| 37364263 | 0 | Khan F, Coyle D, Thavorn K, et al. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study. Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559. | |
| 37308131 | 0 | Gaugler JO, Righini M, Robert-Ebadi H, et al. Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism. Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018. | |
| 37263381 | 0 | Maanen RV, Martens ESL, Takada T, et al. Accuracy of the Physicians' Intuitive Risk Estimation in the Diagnostic Management of Pulmonary Embolism: An Individual Patient Data Meta-Analysis. J Thromb Haemost. 2023 May 30:S1538-7836(23)00438-5. doi: 10.1016/j.jtha.2023.05.023. | |
| 37091135 | 0 | Roberge G, Samson C, Le Gal G, et al. Prolonged Fasting as a Cause of Deep Vein Thrombosis: A Case Report. TH Open. 2023 Apr 20;7(2):e94-e96. doi: 10.1055/s-0043-57225. eCollection 2023 Apr. | |
| 36858345 | 0 | Schenker C, Marx CE, Kraaijpoel N, et al. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. J Thromb Haemost. 2023 Feb 27:S1538-7836(23)00161-7. doi: 10.1016/j.jtha.2023.02.013. | |
| 36740040 | 0 | Robin P, Le Pennec R, Eddy M, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data. J Thromb Haemost. 2023 Feb 3:S1538-7836(23)00084-3. doi: 10.1016/j.jtha.2023.01.030. | |
| 36696189 | 0 | Stals MAM, Moumneh T, Ainle FN, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07639-5. doi: 10.1016/j.jtha.2022.11.025. | |
| 36696183 | 0 | Aziz J, Wang TF, Siegal D, et al. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2022 Dec 27:S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016. | |
| 36609323 | 0 | Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927. | |
| 36521170 | 0 | Robert-Ebadi H, Roy PM, Sanchez O, et al. External validation of the PEGeD diagnostic algorithm for suspected pulmonary embolism in an independent cohort. Blood Adv. 2023 Aug 8;7(15):3946-3951. doi: 10.1182/bloodadvances.2022007729. | |
| 36428830 | 0 | Wauthier L, Favresse J, Hardy M, et al. D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review. Diagnostics (Basel). 2022 Nov 12;12(11):2770. doi: 10.3390/diagnostics12112770. | |
| 36100263 | 0 | Auer RC, Ott M, Karanicolas P, et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375. | |
| 36010225 | 0 | Robert-Ebadi H, Moumneh T, Le Gal G, et al. Diagnosis of Pulmonary Embolism during Pregnancy. Diagnostics (Basel). 2022 Aug 3;12(8). pii: diagnostics12081875. doi: 10.3390/diagnostics12081875. | |
| 35877546 | 0 | Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022 Jul 25. doi: 10.1111/bjh.18331. | |
| 35730241 | 0 | Genge L, Krala A, Tritschler T, et al. Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review. J Thromb Haemost. 2022 Jun 22. doi: 10.1111/jth.15788. | |
| 35717670 | 0 | Tritschler T, Cusano E, Langlois N, et al. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review. J Thromb Haemost. 2022 Jun 19. doi: 10.1111/jth.15787. | |
| 35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
| 35468835 | 0 | Lamb T, Lenet T, Zahrai A, et al. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis. World J Emerg Surg. 2022 Apr 25;17(1):19. doi: 10.1186/s13017-022-00423-1. | |
| 35436439 | 0 | Carrier M, Le Gal G. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation. Ann Intern Med. 2022 Apr;175(4):W43-W44. doi: 10.7326/L22-0038. | |
| 35217330 | 0 | Beaudoin E, Kaka S, Gagnon E, et al. Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study. Thromb Res. 2022 Feb 12;212:19-21. doi: 10.1016/j.thromres.2022.02.001. | |
| 35167861 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12. | |
| 35157815 | 0 | Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731. | |
| 34940092 | 0 | Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453. | |
| 34904857 | 0 | Stals MAM, Takada T, Kraaijpoel N, et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis. Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-2625. | |
| 34807722 | 0 | Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981. | |
| 34795036 | 0 | Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021. | |
| 34753191 | 0 | Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728. | |
| 34671466 | 0 | Akbari A, Kunkel E, Bota SE, et al. Proteinuria and venous thromboembolism in pregnancy: a population-based cohort study. Clin Kidney J. 2021 Jan 11;14(9):2101-2107. doi: 10.1093/ckj/sfaa278. eCollection 2021 Sep. | |
| 34518263 | 0 | Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557. | |
| 34516270 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14. | |
| 34496121 | 0 | Robert-Ebadi H, Elias A, Sanchez O, et al. Assessing the clinical probability of pulmonary embolism during pregnancy: The Pregnancy-Adapted Geneva (PAG) score. J Thromb Haemost. 2021 Sep 8. doi: 10.1111/jth.15521. | |
| 34438079 | 0 | McAlpine K, Breau RH, Werlang P, et al. Timing of Perioperative Pharmacologic Thromboprophylaxis Initiation and its Effect on Venous Thromboembolism and Bleeding Outcomes: A Systematic Review and Meta-Analysis. J Am Coll Surg. 2021 Nov;233(5):619-631.e14. doi: 10.1016/j.jamcollsurg.2021.07.687. Epub 2021 Aug 24. | |
| 34399433 | 0 | Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155. | |
| 34379859 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22. | |
| 34351722 | 0 | Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. | |
| 34351721 | 0 | Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. | |
| 34255928 | 0 | Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1. | |
| 34161671 | 0 | Bellesini M, Robert-Ebadi H, Combescure C, et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2454-2467. doi: 10.1111/jth.15432. Epub 2021 Jul 20. | |
| 33900385 | 0 | Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism. Blood Adv. 2021 Apr 27;5(8):2237-2244. doi: 10.1182/bloodadvances.2020002398. | |
| 33872452 | 0 | Tardy-Poncet B, de Maistre E, Pouplard C, et al. Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation. J Thromb Haemost. 2021 Aug;19(8):1959-1972. doi: 10.1111/jth.15344. Epub 2021 Jun 14. | |
| 33836493 | 0 | Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism? Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25. | |
| 33806140 | 0 | Tardy-Poncet B, Montmartin A, Piot M, et al. Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 2021 Mar 25;9(4). pii: biomedicines9040332. doi: 10.3390/biomedicines9040332. | |
| 33724705 | 0 | Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21. | |
| 33593766 | 0 | Bose G, Graveline J, Yogendrakumar V, et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ Open. 2021 Feb 16;11(2):e040212. doi: 10.1136/bmjopen-2020-040212. | |
| 33405381 | 0 | Le Gal G, Carrier M, Castellucci LA, et al. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Jan;19(1):297-303. doi: 10.1111/jth.15138. | |
| 33351119 | 0 | Siegal DM, Barnes GD, Langlois NJ, et al. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Adv. 2020 Dec 22;4(24):6259-6273. doi: 10.1182/bloodadvances.2020003269. | |
| 33313465 | 0 | den Exter PL, Kroft LJM, Gonsalves C, et al. Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts. Res Pract Thromb Haemost. 2020 Oct 1;4(8):1251-1261. doi: 10.1002/rth2.12422. eCollection 2020 Nov. | |
| 33293309 | 0 | Tritschler T, Langlois N, Hutton B, et al. Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults. BMJ Open. 2020 Dec 7;10(12):e040122. doi: 10.1136/bmjopen-2020-040122. | |
| 33278785 | 0 | Elias A, Schmidt J, Bellou A, et al. Opinion and practice survey about the use of prognostic models in acute pulmonary embolism. Thromb Res. 2021 Feb;198:40-48. doi: 10.1016/j.thromres.2020.10.027. Epub 2020 Nov 1. | |
| 32888372 | 0 | Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1. | |
| 32869501 | 0 | Eddy M, Robert-Ebadi H, Richardson L, et al. External validation of the YEARS diagnostic algorithm for suspected pulmonary embolism. J Thromb Haemost. 2020 Dec;18(12):3289-3295. doi: 10.1111/jth.15083. Epub 2020 Oct 23. | |
| 32788108 | 0 | Robin P, van Es N, Le Roux PY, et al. Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. Thromb Res. 2020 Oct;194:153-157. doi: 10.1016/j.thromres.2020.06.034. Epub 2020 Jun 23. | |
| 32654348 | 0 | Mulder FI, Carrier M, van Doormaal F, et al. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2622-2628. doi: 10.1111/jth.15001. Epub 2020 Aug 4. | |
| 32654308 | 0 | AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28. | |
| 32569377 | 0 | Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis. Blood Adv. 2020 Jun 23;4(12):2779-2788. doi: 10.1182/bloodadvances.2020001558. | |
| 32511715 | 0 | Patel P, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Jun 9;4(11):2516-2522. doi: 10.1182/bloodadvances.2019001409. | |
| 32502594 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2. | |
| 32496023 | 0 | Tritschler T, Kraaijpoel N, Girard P, et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769. | |
| 32299756 | 0 | Gruel Y, De Maistre E, Pouplard C, et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020 Apr;39(2):291-310. doi: 10.1016/j.accpm.2020.03.012. Epub 2020 Apr 13. | |
| 32227213 | 0 | Bhatt M, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Apr 14;4(7):1250-1264. doi: 10.1182/bloodadvances.2019000960. | |
| 32168402 | 0 | Moumneh T, Riou J, Douillet D, et al. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study. J Thromb Haemost. 2020 Jun;18(6):1398-1407. doi: 10.1111/jth.14796. Epub 2020 Apr 16. | |
| 32125293 | 0 | Tritschler T, Castellucci LA, Van Es N, et al. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants. Pol Arch Intern Med. 2020 Jun 6;130(6):529-538. doi: 10.20452/pamw.15225. Epub 2020 Mar 3. | |
| 32073218 | 0 | Tritschler T, Kraaijpoel N, Langlois N, et al. Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts. J Thromb Haemost. 2020 Jun;18(6):1415-1420. doi: 10.1111/jth.14775. Epub 2020 Mar 30. | |
| 32045437 | 0 | Kraaijpoel N, Carrier M, Le Gal G, et al. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis. PLoS One. 2020 Feb 11;15(2):e0228788. doi: 10.1371/journal.pone.0228788. eCollection 2020. | |
| 32036158 | 0 | Robin P, Grewal RK, Le Roux PY, et al. Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism. Thromb Res. 2020 Apr;188:25-27. doi: 10.1016/j.thromres.2020.01.028. Epub 2020 Jan 30. | |
| 31989095 | 0 | Shaw JR, Zhang T, Le Gal G, et al. Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis. Res Pract Thromb Haemost. 2020 Jan 20;4(1):131-140. doi: 10.1002/rth2.12285. eCollection 2020 Jan. | |
| 31925875 | 0 | Blondon M, Le Gal G, Meyer G, et al. Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: A cost-effectiveness analysis. J Thromb Haemost. 2020 Apr;18(4):865-875. doi: 10.1111/jth.14733. Epub 2020 Feb 28. | |
| 31872492 | 0 | Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020 Apr;18(4):926-930. doi: 10.1111/jth.14720. Epub 2020 Feb 17. | |
| 31774957 | 0 | Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-2134. doi: 10.1056/NEJMoa1909159. | |
| 31661033 | 0 | Khan F, Kimpton M, Tritschler T, et al. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol. Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5. | |
| 31582557 | 0 | Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3. | |
| 31380891 | 0 | Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. | |
| 31317483 | 0 | Carrier M, Soff G, Le Gal G. Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants. Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7. | |
| 31301689 | 0 | Kraaijpoel N, Tritschler T, Guillo E, et al. Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: A systematic review. J Thromb Haemost. 2019 Oct;17(10):1590-1607. doi: 10.1111/jth.14570. Epub 2019 Jul 31. | |
| 31141645 | 0 | Carrier M, Le Gal G, Wells PS. Preventing Venous Thromboembolism in Patients with Cancer. Reply. N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003. | |
| 31108013 | 0 | Langlois E, Cusson-Dufour C, Moumneh T, et al. Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT-PE-pregnancy study. J Thromb Haemost. 2019 Aug;17(8):1329-1334. doi: 10.1111/jth.14483. Epub 2019 Jun 5. | |
| 31060047 | 0 | Le Moigne E, Timsit S, Ben Salem D, et al. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019 Jun 4;170(11):756-763. doi: 10.7326/M18-3485. Epub 2019 May 7. | |
| 31038838 | 0 | Shaw JR, Douketis J, Le Gal G, et al. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. J Thromb Haemost. 2019 Jul;17(7):1171-1178. doi: 10.1111/jth.14468. Epub 2019 May 29. | |
| 30890372 | 0 | Reardon PM, Patrick S, Taljaard M, et al. Diagnostic Accuracy and Financial Implications of Age-Adjusted D-Dimer Strategies for the Diagnosis of Deep Venous Thrombosis in the Emergency Department. J Emerg Med. 2019 May;56(5):469-477. doi: 10.1016/j.jemermed.2019.01.027. Epub 2019 Mar 16. | |
| 30656824 | 0 | Righini M, Robert-Ebadi H, Glauser F, et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. J Thromb Haemost. 2019 Mar;17(3):507-510. doi: 10.1111/jth.14387. Epub 2019 Feb 3. | |
| 30592396 | 0 | Girard P, Le Gal G. Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Dec 6;379(23):2279. doi: 10.1056/NEJMc1813803. | |
| 30511879 | 0 | Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. | |
| 30504342 | 0 | Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):426-431. doi: 10.1182/asheducation-2018.1.426. | |
| 30498046 | 0 | Robin P, Eddy M, Sikora L, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data. BMJ Open. 2018 Nov 28;8(11):e023939. doi: 10.1136/bmjopen-2018-023939. | |
| 30482764 | 0 | Lim W, Le Gal G, Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3226-3256. doi: 10.1182/bloodadvances.2018024828. | |
| 30425073 | 0 | Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Blood Adv. 2018 Nov 13;2(21):3081-3087. doi: 10.1182/bloodadvances.2018020230. | |
| 30357273 | 0 | Righini M, Robert-Ebadi H, Elias A, et al. Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study. Ann Intern Med. 2018 Dec 4;169(11):766-773. doi: 10.7326/M18-1670. Epub 2018 Oct 23. | |
| 30326130 | 0 | Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous Thromboembolism: Advances in Diagnosis and Treatment. JAMA. 2018 Oct 16;320(15):1583-1594. doi: 10.1001/jama.2018.14346. | |
| 30268859 | 0 | Robin P, Kumar S, Salaun PY, et al. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thromb Res. 2018 Nov;171:97-102. doi: 10.1016/j.thromres.2018.09.050. Epub 2018 Sep 19. | |
| 30268858 | 0 | Robin P, Otten HM, Delluc A, et al. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thromb Res. 2018 Nov;171:92-96. doi: 10.1016/j.thromres.2018.09.055. Epub 2018 Sep 23. | |
| 30046762 | 0 | Ikesaka R, Langlois N, Carrier M, et al. Pilot trials in thrombosis: Purpose and pitfalls. Res Pract Thromb Haemost. 2018 Jun 13;2(3):572-579. doi: 10.1002/rth2.12117. eCollection 2018 Jul. | |
| 30046758 | 0 | Castellucci LA, de Wit K, Garcia D, et al. Extended anticoagulation for unprovoked venous thromboembolism. Res Pract Thromb Haemost. 2018 Jun 6;2(3):529-534. doi: 10.1002/rth2.12121. eCollection 2018 Jul. | |
| 30031290 | 0 | Rodger MA, Le Gal G, Langlois NJ, et al. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer? Thromb Res. 2018 Sep;169:82-86. doi: 10.1016/j.thromres.2018.07.020. Epub 2018 Jul 17. | |
| 29770793 | 0 | Huisman MV, Barco S, Cannegieter SC, et al. Pulmonary embolism. Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28. | |
| 29680814 | 0 | Le Roux PY, Robin P, Tromeur C, et al. SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcome. BMJ Open. 2018 Apr 21;8(4):e022024. doi: 10.1136/bmjopen-2018-022024. | |
| 29605058 | 0 | Le Gal G, Righini M. Preface to Diagnosis of venous thromboembolism. Thromb Res. 2018 Mar;163:200. doi: 10.1016/j.thromres.2018.02.139. | |
| 29440340 | 0 | Khan F, Le Gal G, Rodger MA. The authors respond to "Thrombophilia testing in venous thromboembolism". CMAJ. 2018 Feb 12;190(6):E172. doi: 10.1503/cmaj.68991. | |
| 29310057 | 0 | Skeith L, Carrier M, Shivakumar S, et al. Guiding curriculum development of a national research training program in thrombosis medicine: A needs assessment involving faculty and trainees. Thromb Res. 2018 Feb;162:79-86. doi: 10.1016/j.thromres.2017.12.008. Epub 2017 Dec 13. | |
| 29224973 | 0 | Wan T, Rodger M, Zeng W, et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Thromb Res. 2018 Feb;162:104-109. doi: 10.1016/j.thromres.2017.11.020. Epub 2017 Dec 8. | |
| 29212129 | 0 | Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6. | |
| 28978463 | 0 | Robin P, Le Roux PY, Tromeur C, et al. Risk factors of occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res. 2017 Nov;159:48-51. doi: 10.1016/j.thromres.2017.08.021. Epub 2017 Sep 28. | |
| 28942356 | 0 | Ikesaka RT, Kahn SR, Galanaud JP, et al. The importance of post thrombotic syndrome as an outcome after deep venous thrombosis: A survey of Canadian thrombosis clinicians. Thromb Res. 2017 Nov;159:13-15. doi: 10.1016/j.thromres.2017.09.015. Epub 2017 Sep 15. | |
| 28874432 | 0 | Khan F, Le Gal G, Rodger MA. Stopping anticoagulation in a woman with unprovoked venous thromboembolism. CMAJ. 2017 Sep 5;189(35):E1112-E1114. doi: 10.1503/cmaj.170327. | |
| 28828492 | 0 | van Es N, Le Gal G, Otten HM, et al. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data. Ann Intern Med. 2017 Sep 19;167(6):410-417. doi: 10.7326/M17-0868. Epub 2017 Aug 22. | |
| 28686913 | 0 | Wan T, Skeith L, Karovitch A, et al. Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies. Thromb Res. 2017 Sep;157:23-28. doi: 10.1016/j.thromres.2017.06.025. Epub 2017 Jun 23. | |
| 28647342 | 0 | Hemon F, Fouchard F, Tromeur C, et al. Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study. Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22. | |
| 28624717 | 0 | Al Megren M, De Wit C, Al Qahtani M, et al. Management of venous thromboembolism in patients with glioma. Thromb Res. 2017 Aug;156:105-108. doi: 10.1016/j.thromres.2017.06.010. Epub 2017 Jun 8. | |
| 28601834 | 0 | van Es N, Le Gal G, Otten HM, et al. Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis. BMJ Open. 2017 Jun 10;7(6):e015562. doi: 10.1136/bmjopen-2016-015562. | |
| 28570648 | 0 | Robin P, Le Roux PY, Lacut K, et al. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism. PLoS One. 2017 Jun 1;12(6):e0178849. doi: 10.1371/journal.pone.0178849. eCollection 2017. | |
| 28528288 | 0 | Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb Res. 2017 Jul;155:101-105. doi: 10.1016/j.thromres.2017.05.006. Epub 2017 May 9. | |
| 28491475 | 0 | Pelletier-Galarneau M, Zannier E, Zuckier LS, et al. Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary Embolism. Thrombosis. 2017;2017:1623868. doi: 10.1155/2017/1623868. Epub 2017 Apr 11. | |
| 28470651 | 0 | Le Gal G, Righini M, Wells PS. Scoring Systems for Diagnosis of Acute Venous Thromboembolism. Semin Thromb Hemost. 2017 Jul;43(5):479-485. doi: 10.1055/s-0037-1601332. Epub 2017 May 3. | |
| 28460260 | 0 | Robin P, Le Roux PY, Le Moigne E, et al. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism. Thromb Res. 2017 Jul;155:6-9. doi: 10.1016/j.thromres.2017.04.022. Epub 2017 Apr 25. | |
| 28363340 | 0 | Righini M, Galanaud JP, Le Gal G. Anticoagulant therapy for symptomatic calf deep vein thrombosis - Authors' reply. Lancet Haematol. 2017 Apr;4(4):e156. doi: 10.1016/S2352-3026(17)30023-6. | |
| 28314711 | 0 | Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065. | |
| 28100960 | 0 | Al Rawahi B, Le Gal G, Auer R, et al. A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients post major abdominal surgery. Thromb J. 2017 Jan 13;15:2. doi: 10.1186/s12959-016-0126-9. eCollection 2017. | |
| 27836513 | 0 | Righini M, Galanaud JP, Guenneguez H, et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol. 2016 Dec;3(12):e556-e562. doi: 10.1016/S2352-3026(16)30131-4. Epub 2016 Nov 8. | |
| 27822904 | 0 | Angriman F, Vazquez FJ, Roy PM, et al. A new prognostic strategy for adult patients with acute pulmonary embolism eligible for outpatient therapy. J Thromb Thrombolysis. 2017 Apr;43(3):326-332. doi: 10.1007/s11239-016-1451-3. | |
| 27465905 | 0 | Delluc A, Tromeur C, Le Ven F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost. 2016 Oct 28;116(5):967-974. doi: 10.1160/TH16-03-0205. Epub 2016 Jul 28. | |
| 27227406 | 0 | Roy PM, Rachas A, Meyer G, et al. Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial. PLoS One. 2016 May 26;11(5):e0154832. doi: 10.1371/journal.pone.0154832. eCollection 2016. | |
| 27086275 | 0 | Rodger MA, Scarvelis D, Kahn SR, et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort. Thromb Res. 2016 Jul;143:152-8. doi: 10.1016/j.thromres.2016.03.028. Epub 2016 Mar 29. | |
| 27031923 | 0 | Gauthier K, Le Gal G, Shivakumar S, et al. Inter-observer reliability of the HERDOO2 clinical decision rule. Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15. | |
| 26826501 | 0 | Vazquez FJ, Gonzalez JP, LeGal G, et al. Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis. Thromb Res. 2016 Feb;138:1-6. doi: 10.1016/j.thromres.2015.12.013. Epub 2015 Dec 17. | |
| 26817957 | 0 | Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27. | |
| 26672686 | 0 | Robin P, Le Roux PY, Planquette B, et al. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Lancet Oncol. 2016 Feb;17(2):193-199. doi: 10.1016/S1470-2045(15)00480-5. Epub 2015 Dec 8. | |
| 26585743 | 0 | Righini M, Robert-Ebadi H, Le Gal G. Diagnosis of pulmonary embolism. Presse Med. 2015 Dec;44(12 Pt 2):e385-91. doi: 10.1016/j.lpm.2015.10.007. Epub 2015 Nov 14. | |
| 26538494 | 0 | Andro M, Delluc A, Moineau MP, et al. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study. Thromb Haemost. 2016 Jan;115(1):169-75. doi: 10.1160/TH15-02-0148. Epub 2015 Nov 5. | |
| 26452982 | 0 | Le Moigne E, Tromeur C, Delluc A, et al. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Haematologica. 2016 Jan;101(1):e12-4. doi: 10.3324/haematol.2015.134882. Epub 2015 Oct 9. | |
| 26272305 | 0 | Castellucci LA, Shaw J, van der Salm K, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res. 2015 Oct;136(4):727-31. doi: 10.1016/j.thromres.2015.07.007. Epub 2015 Jul 14. | |
| 26239706 | 0 | Keeling D, Klok FA, Le Gal G. Controversies in venous thromboembolism--2015. Blood Rev. 2016 Jan;30(1):27-33. doi: 10.1016/j.blre.2015.07.003. Epub 2015 Jul 17. | |
| 26095467 | 0 | Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22. | |
| 25939217 | 0 | Righini M, Le Gal G. [Diagnosis of venous thromboembolism]. Rev Prat. 2015 Feb;65(2):176-81. | |
| 25772935 | 0 | Germain M, Chasman DI, de Haan H, et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet. 2015 Apr 2;96(4):532-42. doi: 10.1016/j.ajhg.2015.01.019. Epub 2015 Mar 12. | |
| 25713501 | 0 | Moretto P, Park J, Rodger M, et al. A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illness. Thromb J. 2015 Feb 14;13:10. doi: 10.1186/s12959-015-0040-6. eCollection 2015. | |
| 25503584 | 0 | Righini M, Le Gal G, Bounameaux H. Venous thromboembolism diagnosis: unresolved issues. Thromb Haemost. 2015 Jun;113(6):1184-92. doi: 10.1160/TH14-06-0530. Epub 2014 Dec 11. | |
| 25491940 | 0 | Delluc A, Le Gal G, Scarvelis D, et al. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients. Thromb Res. 2015 Feb;135(2):298-302. doi: 10.1016/j.thromres.2014.11.020. Epub 2014 Dec 2. | |
| 25455997 | 0 | Le Roux PY, Robin P, Delluc A, et al. Performance of 18F fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism. Thromb Res. 2015 Jan;135(1):31-5. doi: 10.1016/j.thromres.2014.10.008. Epub 2014 Oct 20. |
